AbbVie Inc. (ABBV)
ABBVNYSEBiotechnology: Pharmaceutical Preparations
$293.29
-0.0070 (0.00%) today
Regular session, Nov 10, 1:17 PM ET
- Market cap
- $518.43bn
- P/E
- 22.9
- EPS, last 4 quarters
- $12.83
- Dividend yield
- –
- Day range
- $291.04 to $294.48
- 52-week range
- $190.75 to $302.93
- Average volume
- 7.23m
- Previous close
- $293.30
Analysts
24 coveringBuy20 buy, 4 hold, 0 sell
Targets a year out average $311.41, +6.2% from here
Earnings
next estimate $3.90Next report
Dec 2025
+1.9%
Mar 2026
+1.1%
Jun 2026
+0.3%
Sep 2026
+2.1%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $16.62bn | $15.00bn | $16.99bn | $17.40bn |
| Gross profit | $12.07bn | $10.78bn | $12.70bn | $13.12bn |
| Operating income | $4.54bn | $3.99bn | $6.43bn | $6.27bn |
| Net income | $1.82bn | $695.00m | $3.61bn | $4.22bn |
Last four quarters: revenue $66.01bn, margin 15.7%, free cash flow $18.87bn
News
8 latest- Stock Market Sell-Off: Meet the Unstoppable Vanguard ETF Obliterating the S&P 500 in 2026The Motley Fool · 7 hours ago
- Zacks Investment Ideas feature highlights: Moderna, AbbVie, Eli Lilly and MerckZacks · 1 day ago
- AbbVie's Allergan Reports Higher Facial Satisfaction In Two Studies Of GLP-1 Users RTTNews · 1 day ago
- Moderna (MRNA) Stock Hits 52-Week Highs After Q3 Earnings: Buy, Hold, or Sell?Zacks · 4 days ago
- IRWD Q3 Earnings Beat, Revenues Miss, 2026 View Raised, Stock UpZacks · 4 days ago
- JNJ's Innovative Medicine Unit Grows in Q3 Despite Patent LossesZacks · 4 days ago
- 2 Defensive Healthcare Stocks Hitting New 52-Week Highs: ABBV & LLYZacks · 5 days ago
- 3 Dividend Kings to Buy in November and Never SellThe Motley Fool · 5 days ago
The company
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology - and products and services in our Allergan Aesthetics portfolio.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NYSE
- Region
- North America
- Website
- abbvie.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.